BRCA1-mutated and basal-like breast cancers have similar aCGH profiles and a high incidence of protein truncating TP53 mutations

BACKGROUND: Basal-like breast cancers (BLBC) are aggressive breast cancers for which, so far, no targeted therapy is available because they typically lack expression of hormone receptors and HER2. Phenotypic features of BLBCs, such as clinical presentation and early age of onset, resemble those of b...

Descripción completa

Detalles Bibliográficos
Autores principales: Holstege, Henne, Horlings, Hugo M, Velds, Arno, Langerød, Anita, Børresen-Dale, Anne-Lise, van de Vijver, Marc J, Nederlof, Petra M, Jonkers, Jos
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3002929/
https://www.ncbi.nlm.nih.gov/pubmed/21118481
http://dx.doi.org/10.1186/1471-2407-10-654

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3002929/
https://www.ncbi.nlm.nih.gov/pubmed/21118481
http://dx.doi.org/10.1186/1471-2407-10-654

Ejemplares similares